Thursday, May 12th, 2016

About Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis belongs to a group of lung diseases known as interstitial lung diseases. It affects people in the age group 50-70 years. Diagnosis is effected by the exclusion of other interstitial lung diseases. High-resolution computed tomography (CT) is often employed to confirm the presence of the disease. There is no permanent cure for this disease; therefore, treatment involves relieving underlying symptoms. Nintedanib and pirfenidone are the two approved drugs for the treatment of idiopathic pulmonary fibrosis. Corticosteroids and immunosuppressive drugs are also used for the treatment.

Technavio’s analysts forecast the global idiopathic pulmonary fibrosis market to grow at a CAGR of 23.97% during the period 2016-2020.

Complete report details @        


Covered in this report 
The report covers the present scenario and the growth prospects of the global idiopathic pulmonary fibrosis market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of idiopathic pulmonary fibrosis.

The market is divided into the following segments based on geography: 
• Americas 

Technavio's report, Global Idiopathic Pulmonary Fibrosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Request a sample report @         


Key vendors 
• Baxter International 
• Boehringer Ingelheim 
• F.Hoffmann-La Roche 
• Prometheus Laboratories

Other prominent vendors 
• Afferent Pharmaceuticals 
• Amgen 
• Biogen 
• Bristol-Myers Squibb 
• Cipla 
• FibroGen 
• Gilead Sciences 
• GlaxoSmithKline 
• GNI Group 
• Horizon Pharma 
• ImmuneWorks 
• MediciNova 
• MedImmune (subsidiary of AstraZeneca) 
• Novartis 
• Pfizer 
• Promedior 
• ProMetic Life Sciences 
• Sanofi 
• Shionogi 
• Zai Lab

Market driver 
• Unmet medical need 
• For a full, detailed list, view our report

Market challenge 
• Lack of proper diagnosis 
• For a full, detailed list, view our report

Market trend 
• Patient assistance programs 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

Make an enquiry before buying this Report @   



PART 01: Executive summary 
• Highlights 
PART 02: Scope of the report 
• Market overview 
• Top-vendor offerings 
PART 03: Market research methodology 
• Research methodology 
• Economic indicators 
PART 04: Introduction 
• Key market highlights 
PART 05: Disease overview 
• Understanding the disease 
• Pathogenesis 
• Signs and symptoms 
• Diagnosis 
• Management 
• Epidemiology 
PART 06: Pipeline analysis 
• Lebrikizumab 
• Tipelukast 
• Tralokinumab 
• FG-3019 
• Simtuzumab 
• BMS-986020 
• AF-219 
• SAR156597 
• BG00011 
• PRM-151 
• PBI-4050 
PART 07: Market landscape 
• Market overview 
• Market size and forecast 
• Five forces analysis 
PART 08: Market segmentation by ROA 
• Oral 
• Parenteral 
PART 09: Market segmentation by drug class 
• Systemic corticosteroids 
• Immunosuppressants 
• Tyrosine kinase inhibitors 
• Anti-fibrotic agents 
PART 10: Geographical segmentation 
• Global idiopathic pulmonary fibrosis market by geographical segmentation 2015-2020 
• Idiopathic pulmonary fibrosis market in Americas 
• Idiopathic pulmonary fibrosis market in EMEA 
• Idiopathic pulmonary fibrosis market in APAC 
PART 11: Market drivers 
• Special regulatory designations for pipeline candidates 
• Growth in patient population 
• Unmet medical needs 
PART 12: Impact of drivers 
PART 13: Market challenges 

• Unknown disease etiology 
• Lack of proper diagnosis 
• Increased use of off-label and alternative therapies 
PART 14: Impact of drivers and challenges 
PART 15: Market trends 

• Patient assistance programs 
• Increase in M&A 
• Rise in public awareness 
PART 16: Vendor landscape 
• Competitive scenario 
• Market share analysis 2015 
• Baxter International 
• Boehringer Ingelheim 
• F Hoffmann-La Roche 
• Prometheus Laboratories 
• Other prominent vendors 
PART 17: Appendix 
• List of abbreviations 
PART 18: Explore Technavio 

Buy this report @


Contact US:


Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)          




File Library

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Idiopathic Pulmonary Fibrosis market trend, Idiopathic Pulmonary Fibrosis market segmentation, Idiopathic Pulmonary Fibrosis market analysis, Idiopathic Pulmonary Fibrosis market parameters, Idiopathic Pulmonary Fibrosis industry forecast, Idiopathic




More Formats

View QR Code